Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Malignant Lymphoma

Free Subscription Articles published in Br J Cancer Retrieve available abstracts of 13 articles: HTML format

Single Articles

April 2024
1. ABRAHAO R, Brunson A, Ruddy KJ, Li Q, et al
   Late endocrine diseases in survivors of adolescent and young adult cancer in California: a population-based study.
   Br J Cancer. 2024;130:1166-1175.
   PubMed     Abstract available
   
   
   February 2024
2. LITTLE MP, Mai JZ, Fang M, Chernyavskiy P, et al
   Solar ultraviolet radiation exposure, and incidence of childhood acute lymphocytic leukaemia and non-Hodgkin lymphoma in a US population-based dataset.
   Br J Cancer. 2024 Feb 29. doi: 10.1038/s41416-024-02629.
   PubMed     Abstract available
   
   
   June 2023
3. BEDICS G, Egyed B, Kotmayer L, Benard-Slagter A, et al
   PersonALL: a genetic scoring guide for personalized risk assessment in pediatric B-cell precursor acute lymphoblastic leukemia.
   Br J Cancer. 2023 Jun 21. doi: 10.1038/s41416-023-02309.
   PubMed     Abstract available
   
   
   November 2022
4. SUNGUC C, Hawkins MM, Winter DL, Dudley IM, et al
   Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study.
   Br J Cancer. 2022 Nov 1. pii: 10.1038/s41416-022-02016.
   PubMed     Abstract available
   
   
   October 2022
5. BUTLER EN, Zhou CK, Curry M, McMenamin U, et al
   Testosterone therapy and cancer risks among men in the SEER-Medicare linked database.
   Br J Cancer. 2022 Oct 28. pii: 10.1038/s41416-022-02019.
   PubMed     Abstract available
   
   
   August 2022
6. EKBERG S, Crowther M, Harrysson S, Jerkeman M, et al
   Patient trajectories after diagnosis of diffuse large B-cell lymphoma-a multistate modelling approach to estimate the chance of lasting remission.
   Br J Cancer. 2022 Aug 23. pii: 10.1038/s41416-022-01931.
   PubMed     Abstract available
   
   
   May 2022
7. NOBLE RA, Thomas H, Zhao Y, Herendi L, et al
   Simultaneous targeting of glycolysis and oxidative phosphorylation as a therapeutic strategy to treat diffuse large B-cell lymphoma.
   Br J Cancer. 2022 May 26. pii: 10.1038/s41416-022-01848.
   PubMed     Abstract available
   
   
   November 2021
8. AITAMER M, Akil H, Vignoles C, Branchaud M, et al
   CD20 expression, TrkB activation and functional activity of diffuse large B cell lymphoma-derived small extracellular vesicles.
   Br J Cancer. 2021 Nov 6. pii: 10.1038/s41416-021-01611.
   PubMed     Abstract available
   
   
   October 2021
9. DURAND-PANTEIX S, Monteil J, Sage M, Garot A, et al
   Preclinical study of (212)Pb alpha-radioimmunotherapy targeting CD20 in non-Hodgkin lymphoma.
   Br J Cancer. 2021 Oct 20. pii: 10.1038/s41416-021-01585.
   PubMed     Abstract available
   
   
   
10. HOUNSOME L, Eyre TA, Ireland R, Hodson A, et al
    Diffuse large B cell lymphoma (DLBCL) in patients older than 65 years: analysis of 3 year Real World data of practice patterns and outcomes in England.
    Br J Cancer. 2021 Oct 5. pii: 10.1038/s41416-021-01525.
    PubMed     Abstract available
    
    
    August 2021
11. SMITH MJ, Fernandez MAL, Belot A, Quartagno M, et al
    Investigating the inequalities in route to diagnosis amongst patients with diffuse large B-cell or follicular lymphoma in England.
    Br J Cancer. 2021 Aug 13. pii: 10.1038/s41416-021-01523.
    PubMed     Abstract available
    
    
    May 2021
12. CAI J, Tian X, Ma S, Zhong L, et al
    A nomogram prognostic index for risk-stratification in diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study.
    Br J Cancer. 2021 May 19. pii: 10.1038/s41416-021-01434.
    PubMed     Abstract available
    
    
    December 2020
13. AMERATUNGA M, Brana I, Bono P, Postel-Vinay S, et al
    First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumours.
    Br J Cancer. 2020;123:1730-1736.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.